University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Lacosamide tablets

ESCA

Status: Red Lanreotide (Somatuline Autogel®)

Amber - palliative care use only

Red - oncology, acromegaly

Status: Red Lanreotide (Somatuline® LA)

Amber - palliative care use only

Red - oncology, acromegaly

Status: Green Lansoprazole orodispersible tablets

Second line - for use in swallowing difficulties or via nasogastric tubes.

Status: Amber Lanthanum tablets

Specialist recommendation.

Status: Red Lapatinib tablets

Negative TA

Status: Amber Latanoprost eye drops

Specialist ophthalmologist recommendation

Status: Amber Latanoprost eye drops preservative free (monopost)

Specialist ophthalmogist recommendation. First line preservative free option. For use within license for those patients requiring a preservative free preparation.

Status: Amber Latanoprost with Timolol preservative free (Fixapost®)

Specialist recommendation

Status: Red L-carnitine chewable tablet

NHSE commissioned.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top